MML Investors Services
IDXX icon

MML Investors Services’s Idexx Laboratories IDXX Stock Holding History

MML Investors Services’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83M Buy
5,374
+209
+4% +$117K 0.01% 1326
2026
Q1 		$2.9M Sell
5,165
-90
-2% -$57.7K 0.01% 1109
2025
Q4 		$3.56M Buy
5,255
+1,055
+25% +$718K 0.01% 1046
2025
Q3 		$2.68M Sell
4,200
-596
-12% -$362K 0.01% 1163
2025
Q2 		$2.57M Buy
4,796
+289
+6% +$138K 0.01% 1126
2025
Q1 		$1.89M Sell
4,507
-1,250
-22% -$543K 0.01% 1206
2024
Q4 		$2.38M Sell
5,757
-6,614
-53% -$2.9M 0.01% 1043
2024
Q3 		$6.25M Sell
12,371
-2,429
-16% -$1.18M 0.02% 602
2024
Q2 		$7.21M Sell
14,800
-1,602
-10% -$804K 0.03% 513
2024
Q1 		$8.86M Buy
16,402
+516
+3% +$282K 0.04% 452
2023
Q4 		$8.82M Buy
15,886
+1,889
+13% +$887K 0.04% 408
2023
Q3 		$6.12M Buy
13,997
+514
+4% +$256K 0.03% 470
2023
Q2 		$6.77M Buy
13,483
+1,081
+9% +$518K 0.04% 432
2023
Q1 		$6.2M Sell
12,402
-70
-0.6% -$33.5K 0.04% 398
2022
Q4 		$5.09M Sell
12,472
-196
-2% -$76.1K 0.03% 477
2022
Q3 		$4.13M Buy
12,668
+1,364
+12% +$501K 0.03% 496
2022
Q2 		$3.96M Buy
11,304
+2,325
+26% +$948K 0.03% 497
2022
Q1 		$4.91M Buy
8,979
+980
+12% +$516K 0.03% 450
2021
Q4 		$5.27M Buy
7,999
+756
+10% +$475K 0.04% 424
2021
Q3 		$4.5M Buy
7,243
+171
+2% +$115K 0.04% 443
2021
Q2 		$4.47M Sell
7,072
-2,889
-29% -$1.6M 0.04% 428
2021
Q1 		$4.87M Buy
9,961
+1,848
+23% +$926K 0.05% 377
2020
Q4 		$4.05M Buy
8,113
+1,380
+20% +$617K 0.04% 368
2020
Q3 		$2.65M Buy
6,733
+1,001
+17% +$370K 0.03% 433
2020
Q2 		$1.89M Buy
5,732
+3,743
+188% +$1.08M 0.03% 521
2020
Q1 		$482K Buy
1,989
+552
+38% +$144K 0.01% 894
2019
Q4 		$375K Buy
1,437
+123
+9% +$32.4K 0.01% 1121
2019
Q3 		$357K Sell
1,314
-645
-33% -$179K 0.01% 1091
2019
Q2 		$539K Buy
1,959
+91
+5% +$22.4K 0.01% 987
2019
Q1 		$418K Buy
1,868
+170
+10% +$35.1K 0.01% 1096
2018
Q4 		$316K Buy
1,698
+238
+16% +$48.8K 0.01% 1139
2018
Q3 		$365K Buy
+1,460
New +$354K 0.01% 1178

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

MML Investors Services's IDXX Position: Q2 2026 in Review

MML Investors Services increased its Idexx Laboratories (IDXX) stake by 4% in Q2 2026, buying an estimated $117K and bringing the position to 5,374 shares worth $2.83M. The position accounts for 0.01% of the portfolio, ranked #1326.

MML Investors Services first reported a position in IDXX in Q3 2018 and has held it in 32 quarters since. The position peaked at $8.86M in Q1 2024. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • MML Investors Services held 5,374 shares of Idexx Laboratories worth $2.83M as of Q2 2026.
  • MML Investors Services bought 209 Idexx Laboratories shares in Q2 2026, an estimated $117K.
  • Idexx Laboratories made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #1326 holding.
  • MML Investors Services first reported a position in Idexx Laboratories in Q3 2018 and has held it in 32 quarters since.
  • MML Investors Services's Idexx Laboratories position peaked at $8.86M in Q1 2024.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.